Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Shareholders??? Deficit (Unaudited)

v3.19.1
Condensed Consolidated Statements of Changes in Shareholders’ Deficit (Unaudited) - USD ($)
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2017 $ 45,717 $ 22,127,796 $ (22,854,556) $ (681,043)
Balance, shares at Dec. 31, 2017 45,717,635
Beneficial conversion feature on convertible note payable 260,000 260,000
Stock option exercise compensation 15,000
Accretion of stock option expense 1,444,933 1,444,933
Shares issued for conversion of accrued compensation $ 12,695 650,760 663,455
Shares issued for conversion of accrued compensation, shares 12,694,893
Common shares issued for conversion of debt $ 137 105,696 105,833
Common shares issued for conversion of debt, shares 136,894
Common shares issued for services and prepaid services $ 81 68,669 68,750
Common shares issued for services and prepaid services, shares 80,843
Exercise of stock options $ 323 9,677 10,000
Exercise of stock options, shares 323,373
Net loss (2,286,848) (2,286,848)
Balance at Mar. 31, 2018 $ 58,953 24,682,531 (25,141,404) (399,920)
Balance, shares at Mar. 31, 2018 58,953,638
Balance at Dec. 31, 2018 $ 80,459 31,863,693 (32,759,275) (815,123)
Balance, shares at Dec. 31, 2018 80,459,006
Stock option exercise compensation 7,500 7,500
Common shares issued for services and prepaid services $ 685 113,775 114,460
Common shares issued for services and prepaid services, shares 685,060
Accretion of stock-based compensation 909,375 909,375
Accretion of stock option and warrant expense 586,934 586,934
Net loss (2,360,423) (2,360,423)
Balance at Mar. 31, 2019 $ 81,144 $ 33,481,277 $ (35,119,698) $ (1,557,277)
Balance, shares at Mar. 31, 2019 81,144,066